Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
To estimate the probabilistic cost-effectiveness of cascade screening methods in familial hypercholesterolaemia (FH) from the UK NHS perspective.
|Title:||Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.|
|Keywords:||Adult, Biological Markers, Cardiovascular Diseases, Cholesterol, LDL, Cost-Benefit Analysis, Drug Costs, False Negative Reactions, False Positive Reactions, Genetic Predisposition to Disease, Genetic Testing, Great Britain, Health Care Costs, Heredity, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hyperlipoproteinemia Type II, Markov Chains, Mass Screening, Middle Aged, Models, Economic, Mutation, Pedigree, Predictive Value of Tests, Probability, Prognosis, Quality-Adjusted Life Years, State Medicine, Time Factors|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science
Archive Staff Only